CASI Pharmaceuticals (CASI)
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People’s Republic of China,...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
CASI Pharmaceuticals Analyst Rating
View moreForecast & Rating
Dec 9, 2025Price forecast
$4.001827.71%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · Jul 10 at 02:02 AM
The Market’s Misfit Toys: Who’s Actually Executing and Who’s Fast Asleep?
- Global Report · Jul 9 at 10:02 AM
The Market's Island of Misfit Toys: Who Is Surviving and Who Is Sleepwalking
- Global Report · Jul 9 at 03:32 AM
USD 172.5M Raised and Massive Ethereum Buys: Broad US Equities Accelerate Capital Shifts
- Tip Ranks · Apr 21 at 12:17 PM
CASI Pharmaceuticals Delays Annual 20-F Filing
- Tip Ranks · Mar 3 at 02:39 PM
CASI Pharmaceuticals CEO David Cory to Step Down; Executive Chairman Wei-Wu He Assumes Top Role
- benzinga_article · Feb 25 at 09:07 PM
12 Health Care Stocks Moving In Wednesday's After-Market Session
